Sanarus Technologies
www.sanarus.comSanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. This breast conserving treatment is available at participating breast centers throughout the U.S. The Visica 2 Treatment System has FDA clearance for non-cancerous breast tumors (fibroadenomas). Sanarus is currently sponsoring the FROST Clinical Study for early stage breast cancer that does not involve surgical resection. Our team is constantly working to spread awareness of cryoablation as a treatment option throughout the community as well as major breast cancer organizations throughout the country. We understand that patient awareness and physician adoption are both important factors in making cryoablation the standard of care for breast tumors, and are dedicated to making it available to patients seeking an alternative to surgery. www.sanarus.com www.twitter.com/SanarusTech
Read moreSanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. This breast conserving treatment is available at participating breast centers throughout the U.S. The Visica 2 Treatment System has FDA clearance for non-cancerous breast tumors (fibroadenomas). Sanarus is currently sponsoring the FROST Clinical Study for early stage breast cancer that does not involve surgical resection. Our team is constantly working to spread awareness of cryoablation as a treatment option throughout the community as well as major breast cancer organizations throughout the country. We understand that patient awareness and physician adoption are both important factors in making cryoablation the standard of care for breast tumors, and are dedicated to making it available to patients seeking an alternative to surgery. www.sanarus.com www.twitter.com/SanarusTech
Read moreCountry
State
California
City (Headquarters)
Pleasanton
Industry
Employees
11-50
Founded
2009
Estimated Revenue
$5,000,000 to $10,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Financial Officer
Email ****** @****.comPhone (***) ****-****Member Board of Directors
Email ****** @****.comPhone (***) ****-****Materials Manager
Email ****** @****.comPhone (***) ****-****Clinical Education Specialist
Email ****** @****.comPhone (***) ****-****
Technologies
(10)